BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 3122485)

  • 1. [A patient with systemic lupus erythematosus having IgA- and IgG-lupus anticoagulant and venous thrombosis].
    Okubo S; Yasunaga K; Egawa H; Murata K; Teraoka A
    Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):619-25. PubMed ID: 3122485
    [No Abstract]   [Full Text] [Related]  

  • 2. The lupus anticoagulant in systemic lupus erythematosus.
    Rowell NR; Tate GM
    Acta Derm Venereol; 1989; 69(2):111-5. PubMed ID: 2564226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
    Wong KL; Liu HW; Ho K; Chan K; Wong R
    J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-1990. A 38-year-old woman with fever, skin lesions, thrombocytopenia, and venous thromboses.
    N Engl J Med; 1990 Mar; 322(11):754-69. PubMed ID: 2106624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiphospholipid antibodies: clinical significance in systemic lupus erythematosus].
    Zhou DC; Dong Y; Pan JQ
    Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):78-80, 125. PubMed ID: 2500316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
    McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
    Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticardiolipin antibodies in acquired immunodeficiency syndrome.
    Stimmler MM; Quismorio FP; McGehee WG; Boylen T; Sharma OP
    Arch Intern Med; 1989 Aug; 149(8):1833-5. PubMed ID: 2504122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant and anti-cardiolipin antibody.
    Nakamura H; Uehara H; Okada T; Kambe H; Kimura Y; Ito H; Hayashi E; Yamamoto H; Kishimoto S
    Hepatogastroenterology; 1989 Oct; 36(5):393-7. PubMed ID: 2516008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG binding to endothelial cells in systemic lupus erythematosus.
    Le Roux G; Wautier MP; Guillevin L; Wautier JL
    Thromb Haemost; 1986 Oct; 56(2):144-6. PubMed ID: 2949388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus anticoagulant. A report of 8 cases.
    Agarwal MB; Agarwal UM
    J Assoc Physicians India; 1991 Mar; 39(3):243-5. PubMed ID: 1908857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of determining the levels of lupus anticoagulant and anti-cardiolipin antibodies].
    Alekberova ZS; Nasonov EL; Prudnikova LZ; Aleksandrova LZ; Kurdiashova VF
    Ter Arkh; 1988; 60(7):84-7. PubMed ID: 3145584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus anticoagulant and HIV infection: a prospective study.
    Boue F; Dreyfus M; Bridey F; Delfraissy JF; Dormont J; Tchernia G
    AIDS; 1990 May; 4(5):467-8. PubMed ID: 2115343
    [No Abstract]   [Full Text] [Related]  

  • 13. Post partum renal failure in systemic lupus erythematosus associated with circulating lupus anticoagulant and anticardiolipin antibody.
    Kincaid-Smith P
    Clin Nephrol; 1991 Jul; 36(1):52. PubMed ID: 1909612
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid.
    Asherson RA; Mackay IR; Harris EN
    Br Heart J; 1986 Aug; 56(2):190-3. PubMed ID: 3089242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lupus anticoagulant and epilepsy.
    Finazzi G; Galli M; Viero P; Defanti CA; Tiraboschi L; Barbui T
    Ric Clin Lab; 1987; 17(1):35-9. PubMed ID: 3109006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of antiphosphatidylserine antibodies in patients with lupus anticoagulant. Analysis of 30 cases].
    Zuazu-Jausoro I; Oliver A; Monserrat I; Borrell M; Garí M; Pich I; Grau E; Fontcuberta J
    Med Clin (Barc); 1990 Jul; 95(6):210-3. PubMed ID: 2123507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis].
    Zea Mendoza A; Rodríguez García A; Irigoyen Oyarzábal MV; Vázquez Díaz M; Pardo Vigo A; Mampaso FM; Ortuño Mirete J
    Med Clin (Barc); 1989 May; 92(19):724-8. PubMed ID: 2502695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome.
    Asherson RA; Hughes GR
    J Rheumatol; 1989 Mar; 16(3):378-80. PubMed ID: 2498514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-idiotypic antibodies against anti-phospholipid autoantibodies which suppress lupus-like anticoagulant activity.
    Gris JC; Schved JF; Tousch D; Hereil S; Feugeas O
    Nouv Rev Fr Hematol (1978); 1988; 30(3):143-7. PubMed ID: 3138656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet autoantibodies detected by immunoblotting in systemic lupus erythematosus: association with the lupus anticoagulant, and with history of thrombosis and thrombocytopenia.
    Jouhikainen T; Kekomäki R; Leirisalo-Repo M; Bäcklund T; Myllylä G
    Eur J Haematol; 1990 Apr; 44(4):234-9. PubMed ID: 2111779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.